The clinical trial to examine the efficacy of the intravitreal injection of anti-VEGF antibody Bevacizumab(Avastin) for severe retinopathy of prematurity.
Not Applicable
Recruiting
- Conditions
- Retinopathy of prematurity
- Registration Number
- JPRN-UMIN000018069
- Lead Sponsor
- Gunma University Hospital Department of Ophthalmology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 4
Inclusion Criteria
Not provided
Exclusion Criteria
1)The patient who judged inappropriate as a subject by pediatrician. 2)In addition, the patient who judged an examination responsibility (allotment) doctor to be inappropriate as a subject
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fundus examination
- Secondary Outcome Measures
Name Time Method